Oracle Helidon 3.2.18 Imperative Web Server information disclosure
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.3 | $5k-$25k | 0.00 |
Summary
A vulnerability marked as problematic has been reported in Oracle Helidon 3.2.18. This affects an unknown function of the component Imperative Web Server. This manipulation causes information disclosure. The identification of this vulnerability is CVE-2026-73871. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability was found in Oracle Helidon 3.2.18. It has been declared as problematic. Affected by this vulnerability is an unknown code of the component Imperative Web Server. The manipulation with an unknown input leads to a information disclosure vulnerability. The CWE definition for the vulnerability is CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. As an impact it is known to affect confidentiality. The summary by CVE is:
Vulnerability in the Helidon product of Oracle Fusion Middleware (component: Imperative Web Server). The supported version that is affected is 3.2.18. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Helidon. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Helidon accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
The advisory is shared at oracle.com. This vulnerability is known as CVE-2026-73871 since 08/13/2026. The exploitation appears to be easy. The attack can be launched remotely. The exploitation doesn't need any form of authentication. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 08/19/2026). MITRE ATT&CK project uses the attack technique T1592 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.3
VulDB Base Score: 5.3
VulDB Temp Score: 5.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 5.3
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Information disclosureCWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
08/13/2026 CVE reserved08/19/2026 Advisory disclosed
08/19/2026 VulDB entry created
08/19/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-73871 (🔒)
GCVE (CVE): GCVE-0-2026-73871
GCVE (VulDB): GCVE-100-392389
Entry
Created: 08/19/2026 03:27Changes: 08/19/2026 03:27 (61)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.